Amedisys Inc (AMED)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 32.01% | 40.00% | 40.31% | 46.55% | 52.39% | 44.28% | 43.85% | 43.13% | 43.31% | 43.24% | 43.66% | 44.16% | 44.30% | 44.55% | 44.89% | 43.46% | 42.78% | 41.91% | 40.91% | 41.37% |
| Operating profit margin | 5.41% | 7.79% | 8.41% | 7.39% | 6.99% | 7.57% | 7.42% | 7.84% | 8.13% | 8.23% | 9.05% | 10.40% | 11.38% | 12.06% | 12.41% | 11.54% | 10.58% | 9.83% | 9.24% | 8.94% |
| Pretax margin | 3.67% | 5.80% | 6.27% | 1.43% | 1.77% | 2.32% | 2.18% | 6.77% | 7.21% | 7.47% | 8.44% | 11.51% | 12.66% | 13.39% | 13.73% | 11.23% | 10.18% | 9.31% | 8.63% | 8.55% |
| Net profit margin | 2.89% | 5.49% | 4.89% | -0.02% | 0.46% | 0.12% | 0.10% | 5.02% | 5.34% | 5.45% | 6.33% | 8.59% | 9.44% | 9.98% | 11.25% | 9.53% | 8.86% | 8.22% | 6.50% | 6.43% |
Amedisys Inc's profitability ratios have shown varying trends over the periods analyzed.
- Gross Profit Margin: The gross profit margin has fluctuated between 32.01% and 52.39%, indicating some volatility in the company's ability to generate profit from its revenue after accounting for the cost of goods sold.
- Operating Profit Margin: Amedisys Inc's operating profit margin ranged between 5.41% and 12.41%. The margin demonstrates the company's ability to control its operating expenses and generate profits from its core operations.
- Pretax Margin: The pretax margin declined from 13.73% in June 2021 to as low as 1.43% in March 2024, indicating a significant reduction in the company's profitability before accounting for taxes.
- Net Profit Margin: The net profit margin varied between -0.02% and 11.25%. The negative net profit margin in some quarters suggests that the company experienced periods of losses or very low profitability after accounting for all expenses, including taxes.
Overall, Amedisys Inc's profitability has experienced fluctuations, highlighting the importance of closely monitoring and managing operational and cost-efficiency factors to sustain and improve profitability in the future.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 5.94% | 8.45% | 9.10% | 7.96% | 7.59% | 8.32% | 8.34% | 9.00% | 9.15% | 9.22% | 10.02% | 12.11% | 13.57% | 13.72% | 17.03% | 15.53% | 13.99% | 12.40% | 11.07% | 12.29% |
| Return on assets (ROA) | 3.17% | 5.96% | 5.29% | -0.03% | 0.50% | 0.13% | 0.12% | 5.76% | 6.00% | 6.10% | 7.01% | 10.00% | 11.26% | 11.36% | 15.45% | 12.82% | 11.72% | 10.36% | 7.79% | 8.84% |
| Return on total capital | 11.05% | 13.82% | 17.49% | 16.90% | 16.32% | 19.16% | 17.76% | 16.23% | 17.19% | 18.13% | 20.69% | 24.45% | 27.77% | 30.66% | 32.45% | 31.93% | 27.93% | 26.63% | 25.59% | 27.27% |
| Return on equity (ROE) | 5.97% | 11.11% | 9.96% | -0.05% | 0.97% | 0.25% | 0.23% | 10.40% | 11.28% | 11.91% | 14.23% | 19.74% | 22.45% | 24.32% | 28.27% | 25.59% | 22.69% | 21.97% | 17.79% | 18.75% |
Amedisys Inc's profitability ratios have shown fluctuations over the past few years.
1. Operating return on assets (Operating ROA) ranged between 7.59% to 17.03% during the period under review. A declining trend is observed from March 31, 2024, to December 31, 2024.
2. Return on assets (ROA) varied between -0.03% to 15.45% over the same period. The metric turned negative in March 31, 2024, and gradually recovered in subsequent quarters.
3. Return on total capital ranged from 11.05% to 32.45%. A general decreasing trend can be inferred from December 31, 2023, to December 31, 2024.
4. Return on equity (ROE) fluctuated from -0.05% to 28.27%. Notably, ROE turned negative in March 31, 2024, but improved in the following periods.
Overall, while Amedisys Inc had periods of strong profitability, there were also instances of declines in profitability ratios, indicating the company's performance has been somewhat volatile in recent years. It would be crucial to closely monitor these ratios and the company's operational efficiency to ensure sustained profitability in the future.